Related Experiment Videos

[Clinical epidemiology of primary hyperlipidemia in Japanese population, in comparison with western populations]

M Ishigami1, Y Matsuzawa

  • 1Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 19, 2000
PubMed

Insights

Hyperlipidemia, a risk factor for cardiovascular disease, shows distinct patterns in Japan compared to Western countries. Type IV hyperlipidemia is common in Japanese men, while Type II is prevalent in the West.

Area of Science:

  • Cardiovascular Epidemiology
  • Lipid Metabolism
  • Public Health

Background:

  • Cardiovascular diseases are leading causes of death in Japan.
  • Increasing hyperlipidemia frequency is a suspected background factor.
  • Understanding population-specific epidemiology is crucial for public health initiatives.

Purpose of the Study:

  • To review the clinical epidemiology of hyperlipidemia in the Japanese population.
  • To compare Japanese hyperlipidemia characteristics with Western populations.
  • To highlight unique aspects like hyper HDL cholesterolemia in Japan.

Main Methods:

  • Review of existing epidemiological studies on hyperlipidemia.
  • Comparative analysis of lipid profiles and phenotypes between Japanese and Western cohorts.
  • Examination of trends in serum cholesterol levels.

Main Results:

  • Type IV hyperlipidemia is dominant in Japanese men; Type II is most frequent in Western populations.
  • The gap in serum cholesterol levels between Japanese and Western populations is narrowing.
  • Hyper HDL cholesterolemia is a notable characteristic in the Japanese population.

Conclusions:

  • Hyperlipidemia exhibits distinct phenotypic characteristics between Japanese and Western populations.
  • The epidemiological landscape of hyperlipidemia in Japan is evolving, with a narrowing gap in cholesterol levels compared to the West.
  • Further research into specific lipid disorders like hyper HDL cholesterolemia is warranted for the Japanese population.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...